MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Fennec Pharmaceuticals Inc. Common Stock

FENC

#2933
Fennec Pharmaceuticals Inc. Common Stock
8.49
+1.07%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
8.49
8.49
Intervallo Annuale
4.68
9.92
Variazione giornaliera
+1.07%
Variazione Mensile
+8.57%
Variazione di 6 mesi
-6.29%
Variazione Annuale
+24.12%
Chiusura Precedente
8.40
Open
8.49
Bid
Ask
Low
8.49
High
8.49
Volume
36
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. FENC
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Notizie

Zacks Zacks
CERT FENC
l’altro ieri, 13:15
Certara, Inc. (CERT) Q4 Earnings Lag Estimates
Zacks Zacks
APLS FENC
2026.02.24
Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates
Seeking Alpha Seeking Alpha
FENC
2025.12.22
Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC)
Investing Investing
FENC
2025.12.09
City of Hope to study PEDMARK for hearing protection in testicular cancer
Investing Investing
FENC
2025.12.02
Fennec’s pediatric hearing protection drug shows positive results in Japan
Benzinga Benzinga
FENC
2025.12.02
Pedmark Delivers In Japan Study — Less Hearing Loss, Same Cancer-Fighting Power - Fennec Pharmaceuticals (NASDAQ:FENC)
Investing Investing
FENC
2025.11.19
Fennec Pharmaceuticals repays all outstanding convertible notes
Investing Investing
FENC
2025.11.18
Fennec Pharmaceuticals raises $5 million in non-brokered offering
Investing Investing
FENC
2025.11.17
Fennec Pharmaceuticals raises $40.25 million through public offering
Investing Investing
FENC
2025.11.14
Fennec Pharmaceuticals plans $5 million share offering to existing investors
Investing Investing
FENC
2025.11.14
Fennec Pharmaceuticals prices $35 million public offering
Zacks Zacks
FENC VREX
2025.11.13
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd